A detailed history of Gf Fund Management Co. Ltd. transactions in Geron Corp stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 12,693 shares of GERN stock, worth $32,621. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,693
Holding current value
$32,621
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 18, 2025

BUY
$3.3 - $4.44 $41,886 - $56,356
12,693 New
12,693 $44.9 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $971M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Gf Fund Management Co. Ltd. Portfolio

Follow Gf Fund Management Co. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gf Fund Management Co. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Gf Fund Management Co. Ltd. with notifications on news.